Overview
The purpose of the study is to investigate the superiority of chronic left bundle branch area pacing compared to traditional right ventricular (RV) septal pacing in patients with high-grade conduction disease after transcatheter aortic valve replacement (TAVR). In this investigator initiated, multicenter, prospective, double-blinded, crossover study, chronic left bundle branch area pacing will be compared to chronic right ventricular septal pacing using echocardiographic measures of left ventricular systolic function in patients with a high cumulative ventricular pacing burden after TAVR.
Eligibility
Inclusion Criteria:
- Subject has at least one of these conduction disturbances:
- Symptomatic (or hemodynamically significant) bradycardia or symptomatic persistent atrioventricular block including first-degree and Mobitz I (Wenckebach) or Mobitz type II atrioventricular bock
- High-grade atrioventricular block
- Third-degree atrioventricular block
- Subject has undergone TAVR (any valve system) in the last four weeks
- Subject is receiving a first-time pacemaker implant
- Subject's most recent documented ejection fraction (by any method) within the past 90 days prior to study enrollment is > 50% (≥45% if visually estimated at the time of enrollment)
- Subject is a male or female at least 18 years old at the time of consent
- Subject is able to receive a left sided pectoral implant
Exclusion Criteria:
- Subject has ever had a previous or has an existing implantable pulse generator (IPG), implantable cardiac defibrillator (ICD) or biventricular (BiV) implant
- Subject has more than mild para-valvular regurgitation following TAVR implantation.
- Subject has LVEF < 45% if visually estimated at the time of enrollment
- Subject is indicated for a biventricular pacing device (CRT-P or CRT-D).
- Subject is enrolled in a concurrent study that may confound the results of this study
- Subject has a mechanical heart valve
- Subject is pregnant, or of childbearing potential and not on a reliable form of birth control
- Subject status post heart transplant
- Subject life expectancy less than 2 years